CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)
NCT05704192
·
clinicaltrials.gov ↗
UNKNOWN
Status
373
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Portal Hypertension
Interventions
PROCEDURE:
TACE ± Systemic therapy
Sponsor
Zhongda Hospital